245 related articles for article (PubMed ID: 24738644)
1. Weekly risk of venous thromboembolism recurrence in patients receiving oral anticoagulants.
Laliberté F; Coleman CI; Bookhart B; Lefebvre P; Cloutier M; Damaraju CV; Schein JR; Kaatz S
Curr Med Res Opin; 2014 Aug; 30(8):1513-20. PubMed ID: 24738644
[TBL] [Abstract][Full Text] [Related]
2. Hospitalizations and Other Health Care Resource Utilization Among Patients with Deep Vein Thrombosis Treated with Rivaroxaban Versus Low-molecular-weight Heparin and Warfarin in the Outpatient Setting.
Deitelzweig S; Laliberté F; Crivera C; Germain G; Bookhart BK; Olson WH; Schein J; Lefebvre P
Clin Ther; 2016 Aug; 38(8):1803-1816.e3. PubMed ID: 27491278
[TBL] [Abstract][Full Text] [Related]
3. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
Lin J; Lingohr-Smith M; Kwong WJ
J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
Coleman CI; Bunz TJ; Turpie AGG
Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
[TBL] [Abstract][Full Text] [Related]
5. Temporal Trends in the Practice Pattern for Venous Thromboembolism in Japan: Insight From JROAD-DPC.
Yamashita Y; Morimoto T; Yoshikawa Y; Yaku H; Sumita Y; Nakai M; Ono K; Kimura T
J Am Heart Assoc; 2020 Jan; 9(2):e014582. PubMed ID: 31918600
[TBL] [Abstract][Full Text] [Related]
6. One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events.
Chen SY; Wu N; Gulseth M; LaMori J; Bookhart BK; Boulanger L; Fields L; Schein J
J Manag Care Pharm; 2013 May; 19(4):291-301. PubMed ID: 23627575
[TBL] [Abstract][Full Text] [Related]
7. The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry.
Cohen AT; Gitt AK; Bauersachs R; Fronk EM; Laeis P; Mismetti P; Monreal M; Willich SN; Bramlage P; Agnelli G; Prefer In Vte Scientific Steering Committee And The Prefer In Vte Investigators OBOT
Thromb Haemost; 2017 Jun; 117(7):1326-1337. PubMed ID: 28405675
[TBL] [Abstract][Full Text] [Related]
8. Risk of recurrent venous thromboembolism among deep vein thrombosis and pulmonary embolism patients treated with warfarin.
Nordstrom BL; Evans MA; Murphy BR; Nutescu EA; Schein JR; Bookhart BK
Curr Med Res Opin; 2015 Mar; 31(3):439-47. PubMed ID: 25495136
[TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism in centenarians: Findings from the RIETE registry.
Lacruz B; Tiberio G; Núñez MJ; López-Jiménez L; Riera-Mestre A; Tiraferri E; Verhamme P; Mazzolai L; González J; Monreal M;
Eur J Intern Med; 2016 Dec; 36():62-66. PubMed ID: 27495947
[TBL] [Abstract][Full Text] [Related]
10. Receipt of anticoagulation after venous thromboembolism diagnoses during delivery hospitalizations.
O'Shaugnessy F; Syeda SK; Huang Y; D'Alton ME; Wen T; Wright JD; Friedman AM
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6353-6355. PubMed ID: 33855935
[TBL] [Abstract][Full Text] [Related]
11. Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens.
Trujillo-Santos J; Di Micco P; Dentali F; Douketis J; Díaz-Peromingo JA; Núñez MJ; Cañas I; Mastroiacovo D; Saraiva de Sousa M; Monreal M;
Thromb Haemost; 2017 Jan; 117(2):382-389. PubMed ID: 27786333
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
13. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
[TBL] [Abstract][Full Text] [Related]
14. Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry.
Alatri A; Mazzolai L; Font C; Tafur A; Valle R; Marchena PJ; Ballaz A; Tiraferri E; Font L; Monreal M; Riete Investigators T
Thromb Haemost; 2017 Jul; 117(8):1630-1636. PubMed ID: 28517021
[TBL] [Abstract][Full Text] [Related]
15. Discretionary Thrombophilia Test Acquisition and Outcomes in Patients With Venous Thromboembolism in a Real-World Clinical Setting.
Kozak PM; Xu M; Farber-Eger E; Gailani D; Wells QS; Beckman JA
J Am Heart Assoc; 2019 Nov; 8(22):e013395. PubMed ID: 31696751
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and treatment patterns of patients with venous thromboembolism (VTE) transitioning from hospital to post-discharge settings.
Burton T; Hlavacek P; Guo JD; Rosenblatt L; Mardekian J; Ferri M; Russ C; Kline JA
Hosp Pract (1995); 2020 Oct; 48(4):196-205. PubMed ID: 32720816
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.
Larsen TB; Skjøth F; Kjældgaard JN; Lip GYH; Nielsen PB; Søgaard M
Lancet Haematol; 2017 May; 4(5):e237-e244. PubMed ID: 28411120
[TBL] [Abstract][Full Text] [Related]
18. Cohort Study on the Management of Cancer-Associated Venous Thromboembolism Aimed at the Safety of Stopping Anticoagulant Therapy in Patients Cured of Cancer.
van der Hulle T; den Exter PL; van den Hoven P; van der Hoeven JJ; van der Meer FJ; Eikenboom J; Huisman MV; Klok FA
Chest; 2016 May; 149(5):1245-51. PubMed ID: 26836911
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism recurrence among one-and-done direct oral anticoagulant users: a retrospective longitudinal study.
Alberts M; Zhdanava M; Pilon D; Caron-Lapointe G; Lefebvre P; Bookhart B; Kharat A
Int J Clin Pharm; 2023 Aug; 45(4):952-961. PubMed ID: 37204616
[TBL] [Abstract][Full Text] [Related]
20. Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis.
Becattini C; Giustozzi M; Cerdà P; Cimini LA; Riera-Mestre A; Agnelli G
J Thromb Haemost; 2019 Aug; 17(8):1217-1228. PubMed ID: 31063646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
